Patient consent leadership Dialog Medical’s iMedConsent is already trusted by over 200 hospitals and thousands of physician practices, indicating strong credibility and a large reference base to leverage in outreach to similar health systems seeking standardized, compliant patient communication.

Healthcare system integration As a product now positioned under Standard Register Healthcare, iMedConsent sits within a broader portfolio focused on patient safety and identification, suggesting cross-sell opportunities with existing Standard Register clients and bundled solutions for improving consent workflows.

Regulatory and safety value The solution’s emphasis on reducing risk, enhancing patient safety, standardizing communication, and improving documentation creates compelling value for risk management and compliance teams within hospitals and large health networks.

Expansion-ready market With a revenue range of 10–25 million and deployment across diverse hospitals and practices, Dialog Medical demonstrates scalability potential; SDRs can target mid-to-large health systems seeking to upgrade consent processes and reduce costs.

Tech stack leverage The current tech stack includes modern tooling (Google Analytics/Tag Manager, reCAPTCHA, HSTS) and digital content capabilities, presenting opportunities to enhance user engagement analytics, onboarding efficiency, and security-focused deployment in prospective accounts.